COVID-19对社区队列认知表现的影响:一项COVID症状研究生物库前性队列研究研究
Nathan J Cheetham1, Rose Penfold1,2, Valentina Giunchiglia3
1Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
EClinicalMedicine
|September 1, 2023
概括
在SARS-CoV-2感染后的认知缺陷在近两年后仍然存在,特别是在症状长期存在的人群中. 然而,报告完全康复的个体没有表现出认知障碍,这表明康复是可能的.
科学领域:
- 神经科学是一个神经科学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 认知障碍是SARS-CoV-2感染的一个报告后果.
- 在社区的病例中,长期的认知效应仍未得到充分探索.
- 之前的研究集中在住院的个体上,随访时间有限.
研究的目的:
- 在基于社区的队列中调查SARS-CoV-2感染后认知缺陷的持续性和特征.
- 评估症状持续时间和自我感知恢复对认知功能的影响.
- 为了评估随着时间的推移认知表现的变化.
主要方法:
- 英国COVID症状研究生物库参与者的前性队列研究.
- 用工作记忆,注意力,推理和运动控制测试来评估认知表现.
- 用于估计COVID-19对认知准确性和反应时间的影响的多变量回归模型,调整混因素.
主要成果:
- 与对照组相比,先前感染了SARS-CoV-2的个人表现出较低的认知准确性.
- 缺陷在那些症状持续超过12周的人中最为明显.
- 认知缺陷在感染后持续了近两年,并没有在报告完全康复的个体中检测到.
结论:
- 在SARS-CoV-2感染后的认知缺陷可能是长期的,特别是长期或严重的症状.
- 自我报告的完全康复与没有可检测的认知缺陷有关.
- 需要进一步的研究,以了解持久症状的个体的恢复机制.
相关概念视频
Cognitive Development During Adulthood
155
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
155
Negative and Cognitive Symptoms of Schizophrenia
83
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
83
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Bias in Epidemiological Studies
349
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
349


